|
AMGN
|
Amgen Inc.
|
5.82%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
5.77%
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
5.56%
|
US
|
NASDAQ
|
|
MRNA
|
Moderna, Inc.
|
5.25%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
5.06%
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
3.01%
|
US
|
NASDAQ
|
|
ILMN
|
Illumina, Inc.
|
2.73%
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
2.68%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
2.55%
|
US
|
NASDAQ
|
|
HZNP
|
Horizon Pharma, Inc.
|
1.54%
|
US
|
NASDAQ
|
|
RPRX
|
Royalty Pharma plc
|
1.53%
|
US
|
NASDAQ
|
|
INCY
|
Incyte Corporation
|
1.39%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
1.39%
|
US
|
NASDAQ
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
1.29%
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
1.18%
|
US
|
NASDAQ
|
|
SNY
|
Sanofi
|
1.14%
|
US
|
NASDAQ
|
|
VTRS
|
Viatris Inc.
|
0.95%
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
0.87%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
0.85%
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
0.79%
|
US
|
NASDAQ
|